Table 2.
Comparison of the mean ± S.E of the haematological parameters after 10 days of HAART administration with the control group.
| Parameter | Group A 0 mg/Kg |
Group B 3 mg/Kg |
Group C 6 mg/Kg |
Group D 12 mg/Kg |
Group E 24 mg/Kg |
|---|---|---|---|---|---|
| RBC (×1012/L) | 6.34 ± 0.22 | 7.41 ± 1.05 | 6.89 ± 0.14 | 7.49 ± 1.08 | 4.92 ± 0.20* |
| HB (g/dL) | 11.60 ± 0.40 | 12.95 ± 1.75 | 12.55 ± 0.45 | 13.15 ± 1.95 | 9.40 ± 0.10* |
| PCV (L/L) | 40.50 ± 1.50 | 44.50 ± 6.50 | 42.50 ± 1.50 | 44.00 ± 8.00 | 33.50 ± 0.50* |
| MCHC (g/dL) | 23.70 ± 0.30 | 29.10 ± 0.10 | 29.70 ± 0.30 | 30.00 ± 1.00 | 28.00 ± 1.00 |
| MCV (fL) | 64.20 ± 0.20 | 60.20 ± 0.10** | 62.00 ± 1.00 | 59.00 ± 2.00 | 68.50 ± 1.50β |
| MCH (pg) | 18.30 ± 0.20 | 17.20 ± 0.10* | 18.15 ± 0.25 | 17.75 ± 0.15 | 19.10 ± 1.00 |
| RETICS (%) | 1.35 ± 0.05 | 1.35 ± 0.35 | 1.15 ± 0.15 | 1.50 ± 0.10 | 1.35 ± 0.15 |
| PLAT (×109/L) | 431.50 ± 68.50 | 328.00 ± 55.00 | 370.00 ± 232.00 | 219.00 ± 73.00 | 284.00 ± 223 |
| WBC (×109/L) | 14.05 ± 3.55 | 6.70 ± 0.50 | 9.30 ± 1.10 | 6.60 ± 1.20 | 8.80 ± 3.00 |
| NEUT (%) | 15.00 ± 3.00 | 33.50 ± 2.50* | 24.50 ± 3.50 | 24.00 ± 12.00 | 27.00 ± 1.00 |
| LYMPH (%) | 85.00 ± 3.00 | 65.50 ± 1.50* | 75.50 ± 3.50 | 76.00 ± 12.00 | 73.00 ± 1.00 |
| EOS (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.50 ± 0.50 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| MONO (%) | 0.00 ± 0.00 | 1.00 ± 1.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| BAS (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
RBC: red blood cell, HB: haemoglobin concentration, PCV: packed cell volume, MCHC: mean cell haemoglobin concentration, MCV: mean cell volume, MCH: mean cell haemoglobin, RETICS: reticulocytes, PLAT: platelets, WBC: white blood cell, NEUT: neutrophils, LYMPH: lymphocytes, EOS: eosinophils, BAS: basophils.
*Compared with the control group *P < 0.05, **P < 0.01.
βOne way ANOVA for groups B, C, D, and E βP < 0.05.